scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VACCINE.2018.10.031 |
P698 | PubMed publication ID | 30327212 |
P50 | author | Barbara J Kamicker | Q73173577 |
P2093 | author name string | Douglas E Brough | |
Bryan T Butman | |||
Damodar Ettyreddy | |||
William Hurtle | |||
Carla Bravo de Rueda | |||
Christopher Schutta | |||
David A Brake | |||
John G Neilan | |||
José Barrera | |||
Melia Pisano | |||
Max V Rasmussen | |||
Mariceny Zurita | |||
Bruce G Harper | |||
P2860 | cites work | Review of the Global Distribution of Foot-and-Mouth Disease Virus from 2007 to 2014. | Q30252156 |
Genetic characterisation of the recent foot-and-mouth disease virus subtype A/IRN/2005. | Q36372790 | ||
A continuous bovine kidney cell line constitutively expressing bovine αvβ6 integrin has increased susceptibility to foot-and-mouth disease virus | Q37026441 | ||
Experimental infections using the foot-and-mouth disease virus O/JPN/2010 in animals administered a vaccine preserved for emergency use in Japan | Q37621349 | ||
Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey | Q37709740 | ||
Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle | Q38280242 | ||
Epidemiology of the Foot-and-Mouth Disease Serotype O Epidemic of November 2010 to April 2011 in the Republic Of Korea | Q38449823 | ||
Foot-and-Mouth Disease Impact on Smallholders - What Do We Know, What Don't We Know and How Can We Find Out More? | Q38831972 | ||
Global Foot-and-Mouth Disease Research Update and Gap Analysis: 2 - Epidemiology, Wildlife and Economics. | Q38851221 | ||
Emergence of foot-and-mouth disease virus SAT 2 in Egypt during 2012. | Q38863587 | ||
Foot-and-mouth disease virus serotype A in Egypt | Q39142159 | ||
Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine | Q39944822 | ||
Protective effects of high-potency FMDV O1 Manisa monovalent vaccine in cattle challenged with FMDV O/SKR/2010 at 7 or 4 days post vaccination | Q40090235 | ||
Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle | Q40158399 | ||
Detailed analysis of the CD8+ T-cell response following adenovirus vaccination | Q40344509 | ||
Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine | Q40389704 | ||
Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus | Q40580981 | ||
Protection induced by a commercial bivalent vaccine against Foot-and-Mouth Disease 2010 field virus from Ecuador | Q40659903 | ||
Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge. | Q40856278 | ||
Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate | Q40920483 | ||
Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination | Q41281277 | ||
Protection to homologous and heterologous challenge in pigs immunized with vaccine against foot-and-mouth disease type O caused an epidemic in East Asia during 2010/2011. | Q42228510 | ||
Correction for LaRocco et al., A Continuous Bovine Kidney Cell Line Constitutively Expressing Bovine αVβ6 Integrin Has Increased Susceptibility to Foot-and-Mouth Disease Virus | Q43110569 | ||
Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region. | Q45225160 | ||
Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle | Q45325592 | ||
Recent spread of a new strain (A-Iran-05) of foot-and-mouth disease virus type A in the Middle East | Q45384620 | ||
Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007-2012) circulating in Southeast Asia, East Asia and Far East | Q47160644 | ||
Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine | Q47550239 | ||
Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage. | Q50532178 | ||
Efficacy of a high quality O1/Campos foot-and-mouth disease vaccine upon challenge with a heterologous Korean O Mya98 lineage virus in pigs. | Q51785051 | ||
The need for improved vaccines against foot-and-mouth disease. | Q52653907 | ||
Multimodel Inference: Understanding AIC and BIC in Model Selection | Q56390541 | ||
An improved, rapid competitive ELISA using a novel conserved 3B epitope for the detection of serum antibodies to foot-and-mouth disease virus | Q57092099 | ||
Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve | Q57098605 | ||
P433 | issue | 48 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | foot-and-mouth disease virus | Q1911079 |
foot-and-mouth disease | Q152401 | ||
Adenoviridae | Q193447 | ||
P304 | page(s) | 7345-7352 | |
P577 | publication date | 2018-10-13 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine | |
P478 | volume | 36 |